We help drug developers plan successful launches, achieve sustainable pricing and reimbursement, and secure market access across the MENA region. Our strategies draw on close working relationships with the region’s main health systems, HTA bodies and payers.
Leveraging our in-depth knowledge and relationships with key stakeholders in the MENA region’s most influential healthcare systems, HTAs, and payers, we deliver tailored, action-oriented strategies that navigate the complexities of healthcare systems, optimize pricing and reimbursement outcomes, and drive successful patient access.
Health Policy, Pricing, Reimbursement, and Market Access Strategy
CCHO develops robust strategies that align with MENA-region health policy trends, optimize pricing, and secure favorable reimbursement and market access conditions for our partners’ assets. Our approach integrates thorough market and competitive analysis, stakeholder engagement, and strategic planning to navigate complex regulatory and reimbursement landscapes.
Pricing and Market Access Landscape Assessments
Our thorough landscape assessments provide a clear understanding of the market environment, stakeholder needs, and competitive dynamics, enabling informed strategic decisions. The deep and comprehensive insights gathered through primary and secondary research help CCHO identify pricing and market access opportunities, risks, challenges, mitigation strategies, and evidence generation tactics. This holistic view allows our partners to proactively address access and reimbursement barriers and leverage market opportunities to maximize product access.
Across the unmet need, clinical value, economic value, and policy domains, we analyze:
Launch Readiness Planning
We offer comprehensive launch readiness planning to ensure new products are effectively introduced to the market, meeting regulatory and HTA requirements while achieving rapid uptake. Our services include:
- Pre-launch market preparation
- Coordination between global and regional teams
- Strategic communication and action plans
Managed Entry Agreements and Value-Based Contracting
We help payers and drug developers understand, design and negotiate managed entry agreements and value-based contracts that align incentives across stakeholders, ensuring sustainable access to our partners’ innovative treatments. These agreements help mitigate financial risk and demonstrate the real-world value of novel therapies. Our expertise includes:
- Developing outcome-based pricing models
- Risk-sharing agreements
- Performance metrics to ensure value for payers and patients
Read CCHO’s white paper on managed entry agreements in the MENA region, published in Value in Health Regional Issues (2019). Read the white paper
Every project is designed around your objectives.